Document Detail


Hypothesis: Catheter-based renal sympathetic denervation should be the initial therapy for essential hypertension.
MedLine Citation:
PMID:  22289343     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hypertension affects 30-40% of the adult population in the developed world and is a major risk factor for stroke, myocardial infarction, heart failure, and kidney failure. Though the importance of controlling hypertension is well recognized, only about 50% of patients in the United States actually attain guideline recommended blood pressure goals. Limiting factors include patient noncompliance, suboptimal application of effective medication, and true medication resistance. Renal sympathetic denervation has been used to treat resistant hypertension and appears to be safe and effective and to produce durable results. We hypothesize that renal sympathetic denervation will produce similar results across the spectrum of hypertension severity for which pharmacologic therapy is currently indicated and propose that this is an important hypothesis to be tested in suitably powered randomized trials.
Authors:
Jai R Lakhanpal; Michael J Domanski
Related Documents :
15691273 - Protection against acute porcine lung ischemia/reperfusion injury by systemic precondit...
17905273 - The effects of propofol on cardiac function after 4 hours of cold cardioplegia and repe...
9089533 - Reflex haemodynamic responses caused by distension of the uterus in anaesthetized pigs.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-28
Journal Detail:
Title:  Medical hypotheses     Volume:  -     ISSN:  1532-2777     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
Affiliation:
The Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An immunological basis of hyperphagia driven by GABAergic dysfunction in Prader-Willi Syndrome.
Next Document:  3D facial analysis can investigate vaccine responses.